Andriole Michael T.

PRESIDENT AND CEO at CHIMERIX INC; Chief Financial Officer at ENDOCYTE INC

Sold, on record
$325k
Dollars the filings state
Form 4 sales
5
Latest Feb 13, 2025
Form 144 notices
1
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale ENDOCYTE INCPlan not stated
    Oct 9 2018

    Sold 17,918 shares at $15.56 ($279k)

    Andriole Michael T., Chief Financial Officer

    Sold 11.9% of holdings ($2.3M position)132,082 shares leftFirst sale on recordFiling

  2. 2 Form 144 notice CHIMERIX INCNotice
    Feb 14 +1954 days

    Filed to sell 2,000 shares ($2k)

    Andriole Michael T., Officer

    No 10b5-1 planFirst sale on recordFiling

  3. 3 Form 4 sale CHIMERIX INCNo plan
    Feb 14 same day

    Sold 1,744 shares at $1.04 ($2k)

    Andriole Michael T., PRESIDENT AND CEO

    No 10b5-1 planSold 0.4% of holdings ($467k position)447,021 shares leftFirst sale on recordFollows a Form 144Filing

  4. 4 Form 4 sale CHIMERIX INCNo plan
    Aug 8 +176 days

    Sold 1,285 shares at $0.83 ($1k)

    Andriole Michael T., PRESIDENT AND CEO

    No 10b5-1 planSold 0.3% of holdings ($385k position)462,453 shares leftFiling

  5. 5 Form 4 sale CHIMERIX INCNo plan
    Jan 30 +175 days

    Sold 2,350 shares at $4.10 ($10k)

    Andriole Michael T., PRESIDENT AND CEO

    No 10b5-1 planSold 0.4% of holdings ($2.5M position)616,973 shares leftFiling

  6. 6 Form 4 sale CHIMERIX INCUnusual
    Feb 13 +14 days

    Sold 7,370 shares at $4.52 ($33k)

    Andriole Michael T., PRESIDENT AND CEO

    No 10b5-1 planSold 1.2% of holdings ($2.8M position)609,603 shares left4.2x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (6)

Form 144 notices and Form 4 sales by Andriole Michael T.
Source
Feb 13, 2025CHIMERIX INCPRESIDENT AND CEOForm 4 sale7,370$33k1.2%UnusualSEC
Jan 30, 2025CHIMERIX INCPRESIDENT AND CEOForm 4 sale2,350$10k0.4%No planSEC
Aug 8, 2024CHIMERIX INCPRESIDENT AND CEOForm 4 sale1,285$1k0.3%No planSEC
Feb 14, 2024CHIMERIX INCPRESIDENT AND CEOForm 4 sale1,744$2k0.4%No planSEC
Feb 14, 2024CHIMERIX INCOfficerForm 144 notice2,000$2kNoticeSEC
Oct 9, 2018ENDOCYTE INCChief Financial OfficerForm 4 sale17,918$279k11.9%Plan not statedSEC